Biomedical subjects
George Winter
Publications and source records attributed to George Winter.
Origin of the species.
This article explains how antibiotic resistance occurs and how it has grown since the introduction of antibiotics in the 1940s. It charts the rise of M RSA infections and describes their growing threat.
Global virus alert. How SARS highlighted the risk of viral pandemics.
As recent events involving SARS and bird flu have shown, foreign travel can be a hazardous undertaking. The burden of disease is high with between 20 and 70 per cent of the 50 million people visiting developing countries reporting a travel-associated illness.
On the offensive.
The government has a target of halving the number of MRSA bacteraemias by 2008. A rapid review panel is investigating new equipment, materials and products to boost infection control.
Gut reaction.
One in five people in the UK suffers an infectious intestinal disease (IID) each year. The most common sources are food, and person-to-person and animal-to-human spread. In 2004, a reported 15,898 people suffered IID. Of these, 134 were admitted to hospital and 11 died. The main agents in IID are viruses, bacteria, protozoa, worms and marine biotoxins. Gastroenteritis should always be considered infectious unless there is good evidence to suggest otherwise.
A bug's life.
This article explains what methicillin-resistant Staphylococcus aureus (MRSA) is, how it is spread and what the real challenges are in healthcare settings in the UK. It explores the different strains of MRSA and points out the main ways to control their spread. It is intended to be a reference source for all nurses.
Global resistance.
Explore the source record for details and available documents.
Gone, and all but forgotten.
Explore the source record for details and available documents.
When Louis met Joe.
Explore the source record for details and available documents.
Celebrity bugs: a new generation.
Explore the source record for details and available documents.
Viral oncology.
The first vaccine against major human cancer was developed against the hepatitis B virus in 1984. Since then, researchers have been working to develop further vaccines, including one against human papillomavirus in 1999.